Media Coverage

Illuminating our Microbial Support System to Improve Health →

Dr. Sean Gibbons Gibbons is featured in a video for the Environmental Health and Microbiome Research Center (EHMBRACE).

YouTube

Posted on March 9, 2024

Research unveils effective STEM program models for high school students from historically marginalized communities →

ISB-led research highlights the transformative power of informal STEM learning in addressing societal challenges and the ease with which many organizations could provide these important opportunities.

Phys.org

Posted on March 8, 2024

IMIDs not tied to adverse pregnancy outcomes overall; lupus, APS linked to preterm birth →

An ISB study found that pregnant patients with lupus or antiphospholipid syndrome have a higher risk for preterm birth, although autoimmune diseases in general are “only weakly associated” with adverse pregnancy outcomes.

Healio

Posted on March 6, 2024

Common immune response is found to be protective across many diseases →

ISB researchers offer promising avenues for exploring multi-disease therapeutic strategies.

Medical Xpress

Posted on March 4, 2024

Link Between Inflammatory Disease, Adverse Pregnancy Outcomes Varies →

The association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities.

HealthDay

Posted on February 12, 2024

Comorbidities Weigh Heavily in Immune-Mediated Inflammatory Disease Pregnancy Outcomes →

ISB Associate Professor Dr. Jennifer Hadlock discussed her recent paper showing that comorbidities play a major role in poor birth outcomes, such as preterm birth and low birth weight, in patients with specific autoimmune diseases.

Medscape

Posted on February 7, 2024

Challenging Prevailing Narratives in Healthcare: A Focus on Autoimmune Disease and Pregnancy, and the Importance of Critical Thinking →

An ISB-led research project examining autoimmune disease and pregnancy was cited as an example of encouraging critical thinking.

Medriva

Posted on February 6, 2024

T Cell Receptor Sequences Are the Dominant Factor Contributing to the Phenotype of CD8+ T Cells with Specificities Against Immunogenic Viral Antigens →

ISB President Dr. Jim Heath talked with Science in Seattle in a wide-ranging interview that touched on his paper in Cell Reports showing how T-cell receptors form, his transition from chemistry to biology, challenges facing life scientists, and more.

Science in Seattle

Posted on November 24, 2023

Is AI the Cancer-Fighting Tool We’ve Been Waiting For? →

As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against cancer. ISB President Dr. Jim Heath was interviewed for this extensively reported feature story for Newsweek Magazine.

Newsweek

Posted on November 22, 2023

A Gut Feeling About Precision Medicine →

ISB Associate Professor Dr. Sean Gibbons spoke with Mark O. Martin from the University of Puget Sound. Gibbons talked about how the study of host-associated microbial communities gives us insights into evolution, ecology and human health.

Matters Microbial podcast

Posted on November 10, 2023

Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset →

ISB and NED Biosystems will collaborate on an intriguing clinical trial that aims to use a cocktail of several marketed medications at low doses to reverse cancer’s onset or regrowth. ISB Co-founder Lee Hood and NED Biosystems founder and CEO Rebecca Lambert announced the deal.

Inside Precision Medicine

Posted on November 8, 2023

Is This Microbiome Startup Selling a Wellness Fantasy? →

Sean Gibbons was quoted in this Bloomberg Businessweek story examining Viome and the often questionable microbiome-wellness startup space.

Bloomberg Businessweek

Posted on October 30, 2023

T Cell Discovery Unlocks Potential for Crafting Tailored Immune Responses →

This story published by Inside Precision Medicine covers ISB research showing that the different disease-fighting functions of distinct T cells are determined by the genetically encoded T-cell receptor (TCR) sequence that are unique to those cells. The findings are promising for developing custom immune responses to specific antigens.

Inside Precision Medicine

Posted on October 26, 2023

Adding lifestyle coaching to treatment decreases cognitive decline in early Alzheimer’s →

McKnights Senior Living published a news story detailing results from the ISB-led Coaching for Cognition in Alzheimer’s (COCOA) trial showing that supplementing the standard of care for early-stage Alzheimer’s disease with lifestyle coaching leads to less cognitive decline.

McKnights Senior Living

Posted on October 20, 2023

Computer Model Identifies Which Species Are Important in a Healthy Microbiome →

ISB researchers collaborated on an international research project that found a way to determine which species in the gut are important and how they interact to create a healthy microbiome.

Technology Networks

Posted on October 20, 2023

A systems biology perspective on the gut microbiome →

ISB Associate Professor Dr. Sean Gibbons was a guest on the ISAPP Science, Microbes & Health podcast. In this episode, Gibbons talked about exploring and manipulating the complex ecology of the microbiome with the aim of engineering outputs of this system, as well as the utility of AI in microbiome science and how the microbiome will play a role in personalized medicine in the future, including in the delivery of probiotics and prebiotics.

ISAPP

Posted on October 19, 2023

Long COVID: An explainer and research roundup →

The Journalist’s Resource featured work by ISB researchers showing four predictive factors of long COVID. The Journalist’s Resource was created by Harvard Kennedy School’s Shorenstein Center on Media, Politics and Public Policy as an open-access online publication for journalists.

The Journalist’s Resource

Posted on September 26, 2023

Breakthrough Study: Alzheimer’s Patients Benefit From Lifestyle Coaching, Not Drugs →

The ISB-led prospective randomized controlled trial called COCOA – Coaching for Cognition in Alzheimer’s – showed that supplementing personalized coaching along with the standard of treatment leads to less cognitive decline in early-stage Alzheimer’s patients than standard of care alone.

Healthcare Business Today

Posted on October 18, 2023

What the young can give to the old →

The Economist highlights work by several ISB researchers showing that gut microbiome patterns reflect healthy aging and predict survival in humans. The work was originally published in the scientific journal Nature Metabolism.

The Economist

Posted on September 25, 2023

The Next Revolution In Medicine: Scientific Wellness, AI And Disease Reversal →

Lee Hood and Nathan Price were guests on the Doctor’s Farmacy podcast, and spoke with Dr. Mark Hyman about the future of personalized healthcare through scientific wellness, how AI is changing the medical industry, and much more.

The Doctor’s Farmacy Podcast

Posted on September 20, 2023

Media Coverage

Science Transforming Health

ISB News

Media Coverage

Illuminating our Microbial Support System to Improve Health →

Research unveils effective STEM program models for high school students from historically marginalized communities →

IMIDs not tied to adverse pregnancy outcomes overall; lupus, APS linked to preterm birth →

Common immune response is found to be protective across many diseases →

Link Between Inflammatory Disease, Adverse Pregnancy Outcomes Varies →

Comorbidities Weigh Heavily in Immune-Mediated Inflammatory Disease Pregnancy Outcomes →

Challenging Prevailing Narratives in Healthcare: A Focus on Autoimmune Disease and Pregnancy, and the Importance of Critical Thinking →

T Cell Receptor Sequences Are the Dominant Factor Contributing to the Phenotype of CD8+ T Cells with Specificities Against Immunogenic Viral Antigens →

Is AI the Cancer-Fighting Tool We’ve Been Waiting For? →

A Gut Feeling About Precision Medicine →

Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset →

Is This Microbiome Startup Selling a Wellness Fantasy? →

T Cell Discovery Unlocks Potential for Crafting Tailored Immune Responses →

Adding lifestyle coaching to treatment decreases cognitive decline in early Alzheimer’s →

Computer Model Identifies Which Species Are Important in a Healthy Microbiome →

A systems biology perspective on the gut microbiome →

Long COVID: An explainer and research roundup →

Breakthrough Study: Alzheimer’s Patients Benefit From Lifestyle Coaching, Not Drugs →

What the young can give to the old →

The Next Revolution In Medicine: Scientific Wellness, AI And Disease Reversal →

Sitemap